Manufacture of basic pharmaceutical products

NACE code 21.1 covers the manufacture of basic pharmaceutical products, a critical industry that plays a vital role in the global healthcare ecosystem. This sector is responsible for the production of active pharmaceutical ingredients (APIs), the core components that give medicines their therapeutic effects. The pharmaceutical industry's importance cannot be overstated, as it is instrumental in developing life-saving drugs, vaccines, and other essential medical treatments that improve quality of life and contribute to the overall well-being of populations worldwide.

The manufacture of basic pharmaceutical products typically involves a multi-step process. Key production techniques include chemical synthesis, fermentation, extraction, and purification. Pharmaceutical companies utilize advanced equipment and specialized facilities to ensure the quality, safety, and efficacy of their products throughout the manufacturing cycle.

The pharmaceutical industry relies on a variety of inputs to support its production activities. Key raw materials include organic and inorganic chemicals, enzymes, and other specialized compounds. Manufacturers also require specialized equipment such as reactors, centrifuges, and purification systems. Additionally, the industry depends on a highly skilled workforce of chemists, biologists, and engineers to oversee the complex production processes.

The primary outputs of NACE code 21.1 are active pharmaceutical ingredients (APIs) and other basic pharmaceutical products. These outputs are then consumed by 21.2 Manufacture of pharmaceutical preparations to formulate finished medicinal products, such as tablets, capsules, and injectable solutions. The pharmaceutical industry's outputs are essential for the 86.1 Hospital activities and 86.2 Medical and dental practice activities sectors, which utilize these products to provide healthcare services to patients.